Deltex Medical Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Deltex Medical Group generated cash of -$1,195,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,786,000 last year. Net change in cash is therefore $234,000.
Cash Flow
| 2014 | -1.80M | -835K | 4.10M |
|---|---|---|---|
| 2015 | -1.68M | -475K | -201K |
| 2016 | -1.81M | -558K | 2.32M |
| 2017 | -928K | -292K | 870K |
| 2018 | -1.31M | -214K | 1.87M |
| 2019 | 609K | -201K | -67K |
| 2020 | -68K | -171K | 190K |
| 2021 | -291K | -644K | 502K |
| 2022 | -606K | -744K | 1.41M |
| 2023 | -1.19M | -370K | 1.78M |
DEMG.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 471K | 413K | 853K | 908K | 580K | 219K | 582K | 575K | 2.93M | 1.45M |
Operating activities | ||||||||||
Net income | -1.25M | -1.14M | -967K | -798K | -161K | -1.26M | -2.00M | -2.37M | -3.46M | -2.95M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 133K | 128K | 114K | 143K | 233K | 246K | 265K | 282K | 257K | 256K |
Stock-based compensation expense | 0 | 125K | 95K | 39K | 117K | 0 | 91K | 25K | 343K | 101K |
| Deferred income tax benefit | 0 | 125K | 95K | 39K | 117K | 0 | 91K | 25K | 343K | 101K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 332K | -57K | 148K | 680K | 427K | 52K | 404K | 447K | 141K | 329K |
Inventories | 105K | -48K | 89K | 13K | -235K | 38K | -203K | 53K | 476K | -295K |
Accounts payable | -691K | 306K | 191K | -303K | 212K | -694K | 251K | -455K | 392K | 0 |
Cash generated by operating activities | -1.19M | -606K | -291K | -68K | 609K | -1.31M | -928K | -1.81M | -1.68M | -1.80M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -9K | -744K | -644K | -171K | -260K | -18K | -6K | -26K | -68K | -372K |
Acquisitions Net | 0 | 0 | 0 | 0 | 59K | 18K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -370K | -744K | -644K | -171K | -201K | -214K | -292K | -558K | -475K | -835K |
Financing activities | ||||||||||
Common Stock Issued | 1.88M | 1.34M | 0 | 250K | 322K | 2.08M | 952K | 2.39M | 59K | 4.56M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 144K | 233K | -543K | -23K | -356K | -36K | -28K | -1.03M | -226K | -203K |
Cash used in financing activities | 1.78M | 1.41M | 502K | 190K | -67K | 1.87M | 870K | 2.32M | -201K | 4.10M |
Net Change In Cash | 234K | 58K | -440K | -55K | 328K | 361K | -363K | 7K | -2.35M | 1.47M |
Cash at end of period | 705K | 471K | 413K | 853K | 908K | 580K | 219K | 582K | 575K | 2.93M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |